NASDAQ:MGTX 10 November 2025

MeiraGTx Falls 5.5% as MGTX Shares Slip, Investors Keep Watch Next Week

MeiraGTx Holdings plc is under pressure early this week after a late Friday slide knocked back most of its recent gains from pipeline news and funding headlines. The stock closed at $9.40 on Friday, down 5.5% for the day and 4.3% over the last five sessions, market data shows.

17 May 2026

Biotechnology·NASDAQ:MGTX·Stock Market

Eli Lilly (LLY) Pops on Fresh Deal Spree: MeiraGTx Gene Therapy Tie‑Up, New AI Collaboration, and Leerink Upgrade — Nov. 10, 2025

Eli Lilly and Company opened the week with a burst of dealmaking and Wall Street momentum. The pharma giant announced a rights deal for a pediatric blindness gene therapy from MeiraGTx, unveiled a new AI‑driven discovery partnership, and captured an analyst upgrade with a higher price target—moves that had LLY trading sharply higher intraday. Reuters+2

10 November 2025

Artificial Intelligence·NASDAQ:ADVM·NASDAQ:MGTX·NASDAQ:NVDA·NYSE:LLY·Pharmaceuticals·Stock Market

NASDAQ:MGTX 10 November 2025 - 17 May 2026

MeiraGTx Falls 5.5% as MGTX Shares Slip, Investors Keep Watch Next Week

Eli Lilly (LLY) Pops on Fresh Deal Spree: MeiraGTx Gene Therapy Tie‑Up, New AI Collaboration, and Leerink Upgrade — Nov. 10, 2025